Richtlijn 'Diagnostiek en medicamenteuze behandeling van dementie'

Translated title of the contribution: The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'

W A van Gool, C J Stam, A Steenhoek, A Hagemeijer

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The practice guideline 'Diagnosis and pharmaceutical treatment of dementia' emphasizes that a nosological diagnosis should be made and that it is important to assess the extent of need for care. The guideline recommends the use of diagnostic criteria for the various conditions that can cause dementia. With respect to ancillary investigations, the burden to the patient should be weighed against the benefits of increasing diagnostic confidence. Observation of the course of the disease, laboratory and cerebrospinal-fluid investigations, neuropsychological and EEG examinations, and neuroimaging all increase diagnostic confidence. Treatment with a cholinesterase inhibitor or memantine should always be embedded in a comprehensive-treatment protocol that includes explicit discussion of treatment goals and expectations at baseline, in combination with criteria for starting and stopping treatment. Guidelines for evaluating the effects of treatment with cholinesterase inhibitors or memantine are specified. If psychosis, depression or behavioural disturbances occur in patients with dementia, antidepressants, antipsychotics or anticonvulsants may be indicated.

Translated title of the contributionThe practice guideline 'Diagnosis and pharmaceutical treatment of dementia'
Original languageDutch
Pages (from-to)839-43
Number of pages5
JournalNederlands Tijdschrift voor Geneeskunde
Volume150
Issue number15
Publication statusPublished - 15 Apr 2006

Cite this